Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Medtronic completes $585M acquisition of CathWorks to advance coronary artery disease diagnosis with AI tech
MDT
$79.92
-$0.55 -0.68%

Medtronic completes $585M acquisition of CathWorks to advance coronary artery disease diagnosis with AI tech

Company Fundamentals
20 Apr 2026
PRNewsWire
View Source
Bullish
pluang ai news

Medtronic has finalized its $585 million acquisition of CathWorks, a medical device firm specializing in AI-powered, drug-free coronary artery disease diagnosis technology. CathWorks' FFRangio System offers comprehensive, wire-free physiological assessment from routine angiograms, improving on traditional invasive methods. This acquisition enhances Medtronic's cardiovascular portfolio and aims to expand global access to innovative diagnostic tools, potentially improving patient outcomes and procedural efficiency. The deal follows positive clinical trial results and aligns with Medtronic's strategy to lead digital transformation in cardiovascular care.

More News (MDT)

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...

Market News
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App